Antifungal Combination Therapy in Children with Cancer—A 4-Year Analysis of Real-Life Data of Two Major Pediatric Cancer Centers
Clinical data on antifungal combination therapy are limited, in particular in the pediatric setting. We analyzed real-life data collected in two major pediatric cancer centers over a period of 4 years. Patients were identified in an observational study on children with acute leukemia and lymphoma or...
Main Authors: | Stefan Schöning, Konrad Bochennek, Kathrin Gordon, Andreas H. Groll, Thomas Lehrnbecher |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Journal of Fungi |
Subjects: | |
Online Access: | https://www.mdpi.com/2309-608X/7/8/604 |
Similar Items
-
Incidence and Outcome of Invasive Fungal Diseases in Children With Hematological Malignancies and/or Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Multicenter Study
by: Thomas Lehrnbecher, et al.
Published: (2019-04-01) -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
by: Lourdes Vazquez
Published: (2016-09-01) -
Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach
by: Maria Daniela Bergamasco, et al.
Published: (2021-07-01) -
Antifungal Prophylaxis in Solid Organ Transplant Recipients
by: Şebnem ŞENOL, et al.
Published: (2015-12-01) -
The Current State of Antifungal Stewardship in Immunocompromised Populations
by: William Alegria, et al.
Published: (2021-04-01)